Browsing: first

According to a 2025 poll by KFF (formerly known as the Kaiser Family Foundation), one in eight adults in the U.S. is taking a GLP-1 drug. These medications — the most recognizable are Ozempic® and Wegovy® — were used initially to treat type 2 diabetes, but are now widely used, along with lifestyle and dietary…

Eli Lilly and Company (NYSE:LLY) cleared a notable regulatory hurdle on August 10, when Britain’s drug regulator authorized the company’s oral GLP-1 drug orforglipron, becoming the first country in Europe to approve the pill. Shares of LLY increased more than 2% in response to the announcement, a modest but insightful reaction for a company whose…

OMAHA, Neb. (KLKN) — The Douglas County Health Department (DCHD)  announced the confirmation of a human case of West Nile virus in the county this summer

This week, the U.K.’s healthcare regulatory body approved Eli Lilly’s (NYSE: LLY) weight loss drug orforglipron, sold as Foundayo, for weight management and type 2 diabetes. Unlike Lilly’s other weight loss drug, Zepbound, Foundayo is a pill, not an injectable medication — and that’s a fresh piece of good news for investors

|| LG Electronics will host the first standalone home lifestyle fair for its home lifestyle community “Lifezip” at COEX in Samseong-dong, Seoul, from the 13th to the 16th, expanding its customer experience touchpoints. LG Electronics

The Cleveland Browns are taking a look at a former first-round pick as they consider potential additions ahead of their preseason opener

England is on track to become one of the first countries in the world to eliminate hepatitis C, a dangerous virus that attacks the liver, figures show

The California Department of Public Health confirmed Wednesday that a San Diego County resident has Clade I mpox. County health officials say the patient likely contracted the virus while traveling internationally to an area where Clade I mpox is circulating. 

The British medicines regulator has approved Eli Lilly’s Foundayo pill, marking a first in Europe for weight management and type 2 diabetes treatment

The UK has made history by becoming the first European nation to approve Eli Lilly’s groundbreaking weight management pill, Foundayo, aimed at aiding those with type 2 diabetes. The British Medicines and Healthcare products Regulatory Agency (MHRA) announced its authorization on Monday